What does the Drug Supply Chain Safety Act establish?

The Drug Supply Chain Safety Act (DSCSA) establishes a framework that primarily focuses on the electronic tracking and tracing of prescription drugs throughout the supply chain. This legislation was enacted to help ensure the safety and security of the pharmaceutical supply chain, enhancing the ability to identify and remove potentially harmful drugs from the market.

By implementing a timeline for the electronic tracking of prescription drugs, the DSCSA aims to facilitate the efficient sharing of information between various stakeholders, including manufacturers, wholesalers, and pharmacies. This electronic system is crucial for verifying and tracing drug products as they move from manufacturer to patient, thereby reducing the risk of counterfeit drugs entering the supply chain and improving overall patient safety.

While the other options might refer to important aspects of drug regulation, they do not directly relate to the primary purpose of the Drug Supply Chain Safety Act. For instance, drug pricing, manufacturing restrictions, and advertising regulations are governed by different laws and not specifically covered under the DSCSA. Understanding this context highlights why the focus on electronic tracking aligns perfectly with the aims of the DSCSA.